BroadOak Capital Partners

Halo Labs (formerly Optofluidics) is a venture-backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing, and microfluidics. Its investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year. The company was founded in 2011 and headquartered in Pennsylvania, United States.

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory services. It features a technology platform that serves as a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. The company was founded in 2014 and headquartered in Massachusetts, United States.

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. It was founded in 2014 and is headquartered in Ann Arbor, Michigan.

Avidien Technologies is a manufacturer of innovative liquid handling instruments. Their biotech product, the microPro 300 semi automated 96 channel pipettes, includes a wirelessly connected ipad mini interface and other features in a package.

PhenoVista Biosciences is a niche contract research organization (CRO) providing high content imaging-based phenotypic assay development and screening services. Using state-of-the-art technology, PhenoVista Biosciences performs phenotypic screen feasibility, development, and full-scale campaigns. PhenoVista Biosciences' team of cell biologists work closely with clients to get the data they need on time and on budget.

Accelix is a biotechnology company that helps cell and gene therapy companies to meet their key product QC requirements. It provides an instrument and a room temperature stable cartridge to gather multi-parameter results. The company was founded in 2007 and headquartered in Yerushalayim, Israel.

Gemini Bio-Products manufactures biological products and chemical reagents for the cell culture community globally. It offers cell culture sera, such as fetal bovine, specialized fetal bovine, other non-fetal, human and animal sera; custom and specialized media; and supplements and reagents, including amino acids, antibiotics and antimycotics, culture supplements and albumins, recombinant proteins, attachment factors, and cell dissociation reagents.

PBS Biotech offers single-use bioreactors and process development services for cell product manufacturing. Their single-use bioreactors have the smallest per liter volume footprints and are fully scalable for any stage of the cell culture process, from R&D to clinical to cGMP production. They provide efficient, cost-effective disposable systems and top-notch technical services to help their customers solve complex cell culture challenges.

KromaTiD focuses on advancing the knowledge of genetic abnormalities and diseases by developing molecular cytogenetics assays and reagents. It's molecular cytogenetic and GeneTracker assays discover, detect, and diagnose the range of disease-causing mutations - including inversions and translocations - in a single test. Based on Directional Genomic Hybridization (dGH), KromaTiD's assays generate the sequence, location, and orientation data from single cells, making them ideal for mixed cell population studies Co-founders Andrew Ray, Joel Bedford, Michael Cornforth, and Susan M. Bailey headquartered the company in Fort Collins, Colorado in 2007.

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. It was founded in 2014 and is headquartered in Ann Arbor, Michigan.

Halo Labs (formerly Optofluidics) is a venture-backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing, and microfluidics. Its investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year. The company was founded in 2011 and headquartered in Pennsylvania, United States.

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory services. It features a technology platform that serves as a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. The company was founded in 2014 and headquartered in Massachusetts, United States.

InFuse Holdings operates high-quality, cost-effective ambulatory infusion centers. The infrastructure in the US for infusion therapies is lacking and, in most communities today, infusions centers have a wide range of cost and quality. InFuse Holdings brings best practices – in the workflow, inventory management, scheduling, safety protocols, staffing, customer experience, and outcomes data collection and reporting – to provide patients with a convenient, safe, and caring environment. The ambulatory infusion center model allows InFuse to provide these services at a lower cost than other delivery channels, helping to decrease the overall cost of healthcare for patients, employers, and payors.

Codex DNA is a biology company helping researchers with the tools they need to securely design, code, and create synthetic DNA. The company is on a mission to help scientific researchers in both academic and commercial settings with the hardware, software, materials, and methodologies required to rapidly and accurately write large quantities of synthetic genes. To, in effect, build biology. Its gene synthesis portfolio reduces the turnaround time for synthesizing workflows from weeks and months to days and hours and includes the BioXp system, DNA services, Gibson Assembly reagents, and Vmax chemically competent cells. In addition to automating, speeding, and optimizing DNA design and synthesis, Codex DNA and the BioXp system ensure your designs stay in your hands, marrying speed and security for innovators in drug discovery, vaccine development, precision medicine, and beyond. Co-founded by Dan Gibson — the creator of the industry-standard Gibson Assembly methodology — Codex DNA is attempting nothing less than changing everything.

Halo Labs (formerly Optofluidics) is a venture-backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing, and microfluidics. Its investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year. The company was founded in 2011 and headquartered in Pennsylvania, United States.

BioInformatics, LLC is a market research and advisory firm that serves the life science, medical device, pharmaceutical, and diagnostic industries. The company specializes in both primary and secondary research, providing insights on market size, attractiveness, and product optimization. Key services include product concept testing, pricing strategy analysis, customer satisfaction assessments, and brand strength evaluations. BioInformatics helps clients navigate corporate acquisitions and measure brand loyalty, offering tailored research that informs strategic decisions. With a multidisciplinary team of industry veterans and research experts, the firm supports clients in enhancing their market positioning and developing effective marketing strategies. Founded in 1994 and based in Arlington, Virginia, BioInformatics caters to a diverse clientele, including biotechnology firms, medical diagnostics companies, and professional service providers.

MedCision is the world leader in next-generation automated cell thawing for advanced therapies. The company develops and commercializes technologies that automate and standardize vital preclinical and clinical biologics handling for critical post-manufacturing processes. MedCision’s digitally enabled ThawSTAR® Automated Cell Thawing Systems are designed to replace uncontrolled and highly variable manual methods, de-risking the therapeutic cell thawing process and optimizing cell efficacy. An industry first, ThawSTAR systems optimize cell thawing using a customizable algorithm for each unique cell therapy product and protocol. These systems, combined with MedCision’s ultra-low temperature cold storage and transport solutions, advance near-patient drug management by providing controlled and scalable processing of temperature-sensitive biotherapeutic products.

LabConnect provides global central laboratory services, including routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services for biopharmaceutical, medical device and contract research organizations. LabConnect's unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets and extensive specialized testing expertise means that drug development companies can rely on one provider for all your central laboratory service needs.

Empire leverages genomics technologies, its keen understanding of the medical system, the needs of clinicians to deliver precise and continuous testing expertise for the best in class oncology disease management tools. Empire is a leader in the field of molecular diagnostics services.

Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted to advance the translation of human genetics “laboratory knowledge” into practical medicine applications. The founders also decided to maintain the company’s roots in Michigan with a commitment to supporting the Michigan economy. Today, Rubicon Genomics is a privately held company located in Ann Arbor, Michigan and employs 20 administrative and technical staff. Our innovative products combined with our strategic partnerships have established the company as a leader in pre-analytical amplification technologies that "break the sample barriers" for our customers. Rubicon sells its products into the research and commercial markets directly and through distributors

Diagnostic BioSystems Inc. is committed to enhancing immunohistochemistry results by providing innovative anatomic pathology reagents and systems to improve the practice of pathology. Since the inception, our prime focus has been to provide high quality products and exceptional customer service and support. Diagnostic BioSystems provides cutting-edge in-vitro diagnostics to the anatomic pathology and histology market through direct sales in the domestic market and through international distributors to over 60 countries worldwide. Our product portfolio includes high quality primary and FITC antibodies, autostainer, chromogens, detection kits and a wide range of ancillaries.

Azenta Life Sciences offers life sciences services including genomics, cryogenic storage, automation, and informatics. They offer suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.